Abstract As multiple sclerosis (MS) has long been known to be associated with Leber, hereditary optic neuropathy (LHON), a disease caused by mitochondrial (mtDNA) mutations, in this study we assessed possible involvement of mtDNA point mutation in MS patients. Fifty-two MS patients whose disease was confirmed with revised McDonald criteria and referred to Iranian Center of Neurological Research of Imam Khomeini hospital during 2006-2007 entered the study. Secondary mtDNA mutations, age, gender, clinical disability according to expanded disability status scale (EDSS), course of the disease, and presenting symptoms were the variables investigated in this study. DNA purification was performed by Diatom DNA Extraction Kit. Analysis of data was done by SPSS V11.5. The prevalent mutations with frequency of 19.2% were J, L, and T haplogroups. Haplotype A was more prevalent in patients with younger age of onset (P-value = 0.012) and high proportion of haplogroup H was associated with optic nerve involvement (P-value = 0.015). No motor symptoms were seen in haplogroup H patients. There is no significant relationship between duration of the disease and EDSS in different mutation of mtDNA.
Introduction
Multiple sclerosis (MS) is a chronic disease of the central nervous system with multiple proposed etiologies, that is characterized by focal areas of myelin loss in periventricular and perivenular distribution in association with conspicuous astrocytic proliferation and variable degrees of neuronal and axonal damage (Behan et al. 2002) . Both genetic and non-genetic factors are postulated to be involved in the pathogenesis of the disease (Ebers et al. 1995; Oksenberg and Hauser 1997; Robertson et al. 1996; Robertson et al. 1997 ). The hypothesis that mitochondrial genes may implicate susceptibility to MS is supported by an increasing number of case reports on Leber's hereditary optic neuropathy (LHON) which is associated with mitochondrial DNA (mtDNA) point mutations in patients with MS (Less et al. 1964) , but this association proved difficult to substantiate prior to the development of modern investigative techniques. LHON is a maternally inherited diseases causing severe bilateral visual loss predominantly in young adults (Harding et al. 1992; Riordan-Eva et al. 1995) . It affects males predominantly, and recovery of vision is rare. LHON has been associated with 18 mutations (Wallace et al. 1988; Mitomap 2003) in mtDNA electron transport genes, four of which are felt to play a significant role in etiology of the disease. The most common mutation occurs at nucleotide 11778 in the NADH dehydrogenase-4 (ND4) genes. The ND4/ 11778 (Behan et al. 2002) , ND1/ 3460, and ND6 /14484 (Huoponen et al. 1991; Howell et al. 1991; Johns et al. 1992 ) mutations account for 50, 15, and 10% of the LHON families respectively, while along with the mutation at ND6/ 14459 account for roughly 90% of cases of LHON (Brown et al. 2001) .The double stranded circular molecule of mtDNA is 16569 bp long, consisting of a non-coding control region (D-loop) and coding genes which generally contribute to the electron transport chain (Wallace et al. 1988) . Involvement of mtDNA in determining susceptibility to MS has been hypothesized based on the predominance of mother-to-child transmission in familial cases, occurrence of inflammatory demyelination in LHON, detection of primary LHON mutations (Olsen et al. 1995; Hanefeld et al. 1994 ) and increased frequency of secondary LHON mutations in patients with MS (Hanefeld et al. 1994; Kalman et al. 1995) . Secondary LHON mutations at nucleotide 11 778 or 3,460 among patients with MS suffering from prominent optic neuropathy (PON) have been reported more frequently than expected by chance (Olsen et al. 1995; Hanefeld et al. 1994; Kalman et al. 1995; Mayr-Wohlfart et al. 1996) . Optic neuritis is one of the most common clinical features of MS in different parts of the world as well as Iranian patients (Montazeri et al. 2005) . This study was designed to assess secondary mutation of LHON by PCR method in patients with MS and the association of mutations with age and clinical presentations.
Materials and Methods
Fifty-two patients with MS according to revised McDonald criteria regardless of any type of treatment, who had been referred to the Iranian Center of Neurological Research, were enrolled in the study during [2006] [2007] . All of the patients were informed on the aims of the study and gave them informed consents to the genetic analysis.
Their presenting signs and symptoms were documented before any treatment.
Secondary mtDNA mutations, age, gender, clinical disability according to expanded disability status scale (EDSS), course of the disease, and presenting symptoms were the variables investigated in this study.
DNA Analysis
Peripheral blood samples were collected after obtaining informed consents from the patients. DNA purification was performed by DNA extraction kits (Diatom DNA Extraction Kit). PCR amplification was carried out in a final volume of 50 ml containing 200-300 ng total DNA, 10 pmol of each primer, 2.5 m M MgCl2, 200 lM of each dNTP, and 2 Units Taq DNA polymerase (Roche Applied Science, Germany. The Primers were as follows: 1-Primer ONPF206 (15340-15360 nt) 5 0 -ATC CTT GCA CGA AAC GGG ATC-3 0 and 2-Primer ONPR 77 (110-91 nt) 5 0 -GCT CGG GCT CCA GCG CTC CG-3 0 (Montazeri et al. 2005) . These primers amplified a 1,366-bp sequence encompassing HVS-I in the DLoop of the mtDNA to fetch the 359-bp sequence (16024-16383 nt) for HVS-I. The obtained mtDNA sequences were aligned with a multiple sequence alignment interface CLUSTAL_X for comparison with rCRS. Agarose (2%) or 8-12% polyacrylamide gel was used to separate the amplicons. Fragments were detected on gel using ethidium-bromide. The haplogroups proceeded by using the Cambridge Algorithm (Anderson et al. 1981) .
Data Analysis
Statistical analyse were performed after entering the data by computing frequencies and determination of 95% confidence intervals(C.Is) for each gene mutation and after examining the normality of numeric variables distribution in different states for each mutation via Kolmogrov Smirnov test. Student t-test and Fisher's Exact and Kruskal-Wallis tests were used for analyzing the association of the mutation with numerical and categorical variables respectively by SPSS V11.5.
Results
Out of the 52 patients 39(75%) were female and 13(25%) were male. Female to male ratio was 3:1. The mean age of the patients was 28.23 ± 8.2 years (range 13-45). A positive family history (first and secondary degree) of MS was reported in five (8.3%) patients. The mean EDSS of the patients was 3.93 ± 1.8 (range 0-7.5). Forty-three (82.7%) patients had RR course, while five (9.6%) had SP, three (5.8%) PP, and only one (1.9%) patient presented with a PR course. Most common presenting symptoms were: motor 28 (53.8%) followed by optic nerve involvement, sensory, cerebellar brainstem, and seizure, 14 (26.9%), 12 (23.1%), 6 (11.5%), and 1 (11.9%) respectively. The frequency of each primary clinical manifestation in patients is shown in Table 1 . The most common mtDNA mutation were seen in L, J, and T haplogroups (19.2%), followed by K and D mutation(13.5%), and 9.6% of patients had A, U, and H haplogroup mutation. Prevalence of each type of mtDNA mutation in patients has been presented in Tables 2 and 3 . We could not find any significant correlation between disability scores, courses of disease and presenting symptoms with different types of mutations (Table 4) . Five (19.6%) patients with type A mutation were younger in age of onset (mean age 19.6 years old) compared with non-mutant group and younger age in onset is statistically significant in patients with type A mutation (P = 0.012; (Table 5) .
Four (80%) patients with H mutation had presented with optic neuritis as their first clinical events, whereas only 10 (21.3%) of the patients without H mutation had presented with this complaint (Table 6 ).This difference was statistically significant applying Fisher Exact test (P = 0.015). In the case of 28 (59.6%) patients who did not have H mutation, motor signs or symptoms were initial clinical events; on the other hand, none of the patients with H mutation had presented with motor syndrome. (Table 7) , (Pvalue = 0.016, Fisher's Exact Test).
There is no significant relationship between duration of disease and EDSS at the time of presentation in different mutations of mtDNA.
Discussion
The MS has been shown to be associated with LHON, a disease that is caused by mtDNA mutations. Vanopdenbosch et al. (2000) showed that the association of LHON and MS is more than a coincidence. Mihailva, showed that mutation of T4 216C may be predisposing marker for MS (Mihailova et al. 2007 ). In our study, the most prevalent mutations were J, L, and T. This result is the same as another report from Iranian patients , and these haplogroups may be a predisposing factor for MS in Iranian patients. In this study 4(80%) of haplogroup H individuals had visual optic involvement in contrast to Reynier study, that showed haplogroup J has the most association with optic neuritis (Reynier et al. 1999 ), but (Otaegu et al. 2004) showed the prevalence of J, T haplogroup is lower in MS patients with optic neuritis involvement. This trend could be a protective effect of this haplogroup in development of optic neuritis in MS patients.
None of the H-mutant patients had motor syndrome, so this haplogroup may be a protective factor for motor syndrome. Other primary symptoms had no correlation with haplogroups. Table 4 Relationship between mtDNA mutation and presenting symptoms, course of disease, and disability Mutation type Considering the result of association of haplogroup A mutation with age of onset, it seems that we can anticipate that later generation in an affected family with haplogroup A mutation manifest the disease at younger ages than previous generation, although anticipation phenomenon has not been widely documented in MS. Trojano et al. (1999) find an anticipation effect in a set of Italian multiplex families based on genetic factors. Another study on Sardinian families also found evidence of anticipation; however, the authors attributed it to widespread environmental changes (Cocco et al. 2004) . The difference between our data with other studies may be due to racial and geographical factors. Our study was limited by small sample size and the number of the patients who had presented with optic neuritis. Future extensive studies should be performed to clarify the exact association of mtDNA mutation and multiple sclerosis. 
